Navigation Links
hESC Products Market: Human Embryonic Stem Cell Patent IP Landscape Opportunity Analysis in New Research Report
Date:8/2/2013

DALLAS, Aug. 2, 2013  /PRNewswire-iReach/ -- This market research report explores the complex IP landscape affecting development of human embryonic stem cell products, providing clear guidance for companies entering or already within the market, from collaborating with WARF to less costly alternatives - such as circumventing the claims, conducting research off-shore, and developing embryonic stem cell products for other species. The report also gives you a wealth of valuable market data to ensure you develop and market products in this stem cell sector effectively. Understand historical and future growth projections, view competitive analysis of providers of hESC research tools and a breakdown of product categories. Learn this and much more in this leading 133-page market intelligence report "Opportunities in Human Embryonic Stem Cell Products" @ http://www.reportsnreports.com/reports/10600-opportunities-in-human-embryonic-stem-cell-hesc-products.html. This report will help you understand the market entry challenges you face and give you the expert advice to overcome the patent IP structure of the industry. Couple this with market leading intelligence data and this report is a must have if you're looking to outcompete your rivals in this expanding and highly profitable market.

(Photo: http://photos.prnewswire.com/prnh/20130802/MN57791)

The major reason for offering this report with up-to-date data and information is to guide biotechnology and pharmaceutical companies with cost-effective development of hESC products. "The report will assist companies with smart product development decisions and the development of high-demand products. Other publishers are broad-spectrum publishers and do not hire specialists who are college educated and laboratory trained to have detailed stem cell industry knowledge. We leverage relationships with active laboratory scientists to provide companies with an understanding of how to best approach the patent landscape and produce products that will experience high demand and low competition within the marketplace" says the Head of Product Development for BioInformant Worldwide LLC, the author of this report.

The report is available for purchase @ http://www.reportsnreports.com/Purchase.aspx?name=10600.

Key Findings Include:

  • Trends for hESC Grants, Scientific Publications, and Patents
  • Market Size Determination for the hESC Product Market
  • 5-Year Market Size Projections (2013-2017)
  • Embryonic Stem Cell Patent Restrictions and Strategies to Circumvent Claims
  • Geographical Breakdown (Leading Countries Conducting hESC Research)
  • Breakdown of Embryonic Stem Cell Research, by Application and Species
  • Competitive Analysis of hESC Research Supply Vendors
  • Overview of Specialty Pharma Companies Developing Embryonic Stem Cell Therapies
  • Overview of Toxicology Testing Legislation (impacting use of hESC in toxicology applications)
  • Crucial Trends and Unmet Market Needs
  • And Much More

 

hESC product market competitors discussed in this report include: Cellartis AB, Vitrolife, Tataa Biocenter, Invitrogen, Stem Cell Technologies, BD Biosciences, Chemicon, R&D Systems, SA Biosciences, Thermo Scientific and Australian Stem Cell Centre.

 

Specialty pharmaceutical companies developing hESC therapies profiled in this report include: Geron, Novocell, Cell Cure Neurosciences Ltd, Cell Dynamics International and Advanced Cell Technology.

 

Comprehensive Table of Contents and more on this report @ http://www.reportsnreports.com/reports/10600-opportunities-in-human-embryonic-stem-cell-hesc-products.html.

 

Explore more reports on the Stem Cell Market @ http://www.reportsnreports.com/tags/stem-cell-market-research.html.

 

About Us:

ReportsnReports.com is an online market research reports library of 350,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers. Call +1 888 391 5441 with your research requirements.

Media Contact: Priyank Tiwari, ReportsnReports.com, +1 888 391 5441, sales@reportsandreports.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE ReportsnReports
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. The new frontier: Creating and marketing food products that prevent disease and obesity
2. REFORM, opening up the way for low environmental impact products
3. Researchers building stronger, greener concrete with biofuel byproducts
4. Biomass research collaboration seeks to improve biofuel efficiency, bio-products quality
5. DNA barcoding alone sufficient to detect fraudulent deer products
6. AZTI-Tecnalia is turning vegetable by-products destined for landfills into feedstuff
7. Increasing evidence links high glycemic index foods and dairy products to acne
8. Dont trust liposomes in your beauty products
9. The pros and cons of ecolabels in cleaning products
10. Cows fed flaxseed produce more nutritious dairy products
11. Experts believe plain packaging of tobacco products would cut smoking
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... and PORTLAND, Ore. , Feb. ... the Avamere Family of Companies (Avamere Health Services, Infinity ... a six-month research study that will apply the power ... at senior living and health centers. By analyzing data ... to gain insights into physical and environmental conditions, and ...
(Date:2/14/2017)... -- Wake Forest Baptist Medical Center today announced Julie Ann Freischlag, ... (CEO). Freischlag joins the medical center on May 1 ... who last year announced that he would transition to ... it since 2008.   As CEO, Freischlag ... academic health system, which includes Wake Forest School of ...
(Date:2/10/2017)... , Feb 10, 2017 Research ... report "Personalized Medicine - Scientific and Commercial Aspects" ... ... medicine. Diagnosis is integrated with therapy for selection of treatment ... early detection and prevention of disease in modern medicine. Biochip/microarray ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... 2017 Research and Markets has announced ... report to their offering. ... The Global Market for Bioproducts Should ... at a CAGR of 8.9%, This research ... into seven major product segments: bio-derived chemicals, biofuels, pharmaceuticals (biodrugs ...
(Date:3/23/2017)... , March 23, 2017  GlobeImmune, Inc. today announced ... the sale of 12,835,490 shares of its common stock ... of companies. In connection with the sale of its common ... cash and issue to GlobeImmune 200,000 shares, an estimated ... "We are pleased to enter into this ...
(Date:3/23/2017)... 2017 Kineta, Inc., a biotechnology company ... in immuno-oncology, today announced the discovery and characterization ... that activate interferon response factor 3 (IRF3) via ... tumor regression in a murine colon carcinoma mouse ... complete tumor regression to initial drug treatment were ...
(Date:3/23/2017)... March 23, 2017  Agriculture technology company Cool Planet ... and note conversion to commercialize its Cool Terra and ... on developing products that are simultaneously profitable as well ... the last 18 months. This latest round of funding ... Partners. The company,s primary product, Cool ...
Breaking Biology Technology: